Atlas Trials

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Clinical trial NCT04140526 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04140526
Sponsor
OncoC4, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic MelanomaMetastatic Head and Neck CarcinomaMetastatic Renal Cell CarcinomaMetastatic Colorectal CancerSarcomasMetastatic Prostate CancerOvarian CancerSmall Cell Lung CancerMetastatic Breast CancerPancreas Cancer
Start date
2020-09-16
Primary completion
2026-06-30
Enrollment
733

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.